Database
User
| Full Name | ATP synthase |
|---|---|
| Subcellular Location | Cell membrane Cytoplasm Extracellular side Matrix side Mitochondrion Mitochondrion inner membrane Mitochondrion membrane Multi-pass membrane protein Peripheral membrane protein Single-pass membrane protein |
| EC numbers | 7.1.2.2 |
| Compound | Dose | Time | Species | Model | Method | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| Leucinostatin | 11 μg/mg protein | C. asciculate | SMP-ATPase | Positive | IC50 | 131 | ||
| Leucinostatin | 2 μg inhibitor/ml | spinach | chloroplast | Positive | IC50 | 132 | ||
| Leucinostatin | 0.1-0.4 μg/mg protein | rat | isolated liver mitochondria | Positive | 133 | |||
| efrapeptins | 0.56 mol/mol F1 | bovine | heart MF1-ATPase | Positive | IC50 | 134 | ||
| efrapeptins | 70 ng/ml | C. asciculate | MF1-ATPase | Positive | IC50 | 135 | ||
| efrapeptins | 0.3 μM | human | umbilical vein endothelial cell, nonmitochondrial ATP synthase | Positive | IC50 | 136 | ||
| efrapeptins | 0.5 μg/ml | R. rubrum | chromatophores | Positive | IC50 | 137 | ||
| efrapeptins | 0.05-0.5 μg of inhibitor/mg protein | T. pyriformis | SMP-ATPase | Positive | IC50 | 138 | ||
| efrapeptins | 21.5 μM | EF1-ATPase | Positive | ki | 139 | |||
| efrapeptins | 10 nM | bovine | heart MF1-ATPase | Positive | kd | 134 | ||
| efrapeptins | 2.4 mol inhibitor/mol enzyme | bovine | heart SMP-ATPase | Positive | complete inhibition | 134 | ||
| resveratrol | 27.7 μM | rat | brain SMP, ATP synthesis | Positive | 140 | |||
| resveratrol | 14 μM | rat | liver MF1-ATPase | Positive | 141 | |||
| resveratrol | 19 μM | rat | brain M F0F1-ATPase | Positive | 140 | |||
| resveratrol | 6.4 μM | bovine | bovine heart MF1-ATPase | Positive | 142 | |||
| resveratrol | 2 μM | human | human umbilical vein endothelial cell, nonmitochondrial ATP synthase, ATP synthesis | Positive | 136 | |||
| Diethylstilbestrol | 10 μM | rat | liver MF0F1-ATPase | Positive | 143 | |||
| Diethylstilbestrol | 10-25 μM | rat | brain MF0F1-ATPase | Positive | 141 | |||
| SITS | ∼1.3 μM | V. parahaemolyticus | F0F1-ATPase | Positive | 144 | |||
| SITS | 25 μM | V. parahaemolyticus | F1-ATPase | Positive | 95% inhibition | 145 | ||
| DIDS | 20.9 μM | rat | liver MF1ATPase | Positive | 146 | |||
| quercetin | 5 kmol/mol | bovine | heart MF1-ATPase | Positive | IC50 | 147 | ||
| quercetin | 85 μM | bovine | heart MF1-ATPase | Positive | IC50 | 148 | ||
| quercetin | 180 μM | bovine | heart SMP-ATPase | Positive | IC50 | 148 | ||
| quercetin | 50 μM | rat | brain F0F1-ATPase | Positive | IC50 | 140 | ||
| quercetin | 3 μM | rat | liver F1-ATPase | Positive | IC50 | 141 | ||
| quercetin | 2 kmol/mola | spinach | CF1-ATPase | Positive | 147 | |||
| quercetin | 2.6 μg/mg protein | C. asciculate | SMP-ATPase | Positive | IC50 | 131 | ||
| quercetin | 0.2 mM | pig | heart MF1-ATPase | Positive | Ki | 149 | ||
| quercetin | 27 μM | bovine | heart MF1-ATPase | Positive | Kd | 147 | ||
| quercetin | 5 μM | C. thermoaceticum | membrane-bound F0F1-ATPase | Positive | 46% inhibition | 150 | ||
| kaempferol | 55 μM | rat | brain MF0F1-ATPase | Positive | IC50 | 140 | ||
| morin | 60 μM | rat | brain MF0F1-ATPase | Positive | IC50 | 140 | ||
| apigenin | 105 μM | rat | brain MF0F1-ATPase | Positive | IC50 | 140 | ||
| genistein | 55 μM | rat | brain MF0F1-ATPase | Positive | IC50 | 140 | ||
| genistein | 50 μM | rat | liver F1-ATPase | Positive | 10% inhibition | 141 | ||
| Biochanin A | 65 μM | rat | brain MF0F1-ATPase | Positive | IC50 | 140 | ||
| Daidzein | 127 μM | rat | brain MF0F1-ATPase | Positive | IC50 | 151 | ||
| Oligomycin | 152 μg inhibitor/mg protein | E. coli | membrane vesicle | Positive | IC50 | 152 | ||
| Oligomycin | 7.1 μg inhibitor/mg protein | C. asciculate | SMP-ATPase | Positive | IC50 | 131 | ||
| Oligomycin | 2.0-3.0 μg inhibitor/mg protein | S. cerevisiae | SMP-ATPase | Positive | IC50 | 153 | ||
| Oligomycin | 0.3 μM | human | NCI-60 cell lines, F0F1-ATPase | Positive | IC50 | 154 | ||
| Oligomycin | 15 ng inhibitor/mg protein | N. crassa | SMP-ATPase | Positive | Ki | 155 | ||
| Oligomycin | 0.21 μM | bovine | heart MF0F1-ATPase | Positive | Ki | 156 | ||
| Oligomycin | 0.4 μg inhibitor/mg protein | bovine | heart SMP-ATPase | Positive | 95% inhibition | 157 | ||
| Oligomycin | 0.5 μg/ml | rat | liver SMP-ATPase | Positive | 75% inhibition | 158 | ||
| peliomycin | 4.5 μg inhibitor/mg protein | S. cerevisiae | SMP-ATPase | Positive | IC50 | 153 | ||
| venturicidin B | 9 μg inhibitor/mg protein | E. coli | membrane vesicle | Positive | IC50 | 152 | ||
| mefloquine | Positive | 35 | ||||||
| venturicidin B | 11 μg inhibitor/mg protein | E. coli | membrane-bound ATPase | Positive | IC50 | 152 | ||
| venturicidin B | 0.06-0.18 (A and B) and 11.0 (X) μg inhibitor/mg protein | S. cerevisiae | SMP-ATPase | Positive | IC50 | 159 | ||
| venturicidin B | 5-11 μg inhibitor/mg protein | T. pyriformis | Positive | IC50 | 138 | |||
| venturicidin B | 0.13 μg inhibitor/mg protein | Positive | IC50 | 153 | ||||
| venturicidin B | 3.0 μg/mg protein | C. asciculate | SMP-ATPase | Positive | IC50 | 131 | ||
| venturicidin B | 0.5 μM | spinach | thylakoids | Positive | IC50 | 160 | ||
| venturicidin B | 0.5 μM | spinach | thylakoids, ATPase | Positive | IC50 | 160 | ||
| ossamycin | 1.3 μg of inhibitor/mg protein | S. cerevisiae | SMP-ATPase | Positive | IC50 | 153 | ||
| ossamycin | 46 μg of inhibitor/mg protein | E. coli | membrane vesicle | Positive | IC50 | 152 | ||
| ossamycin | 8 μM | human | NCI-60 cell lines, F0F1-ATPase | Positive | IC50 | 154 | ||
| paroxetine | Positive | 35 | ||||||
| apoptolidin | 4-5 μM | S. cerevisiae | membrane-bound F0F1-ATPase | Positive | Ki | 161 | ||
| apoptolidin | 18 μM | human | NCI-60 cell lines, F0F1-ATPase | Positive | IC50 | 154 | ||
| cytovaricin | 1 μM | human | NCI-60 cell lines, F0F1-ATPase | Positive | IC50 | 154 | ||
| cytovaricin | 0.4 μM | S. cerevisiae | membrane-bound F0F1-ATPase | Positive | Ki | 161 | ||
| ossamycin | 0.8 μM | 60 human cancer cell lines of the National Cancer Institute | Positive | mean | 184 | |||
| Tamoxifen | Positive | 35 | ||||||
| Oligomycin | Positive | 35 | ||||||
| Oligomycin | 8.7 | LUHMES (Lund human mesencephalic) cells | Glc–Gal–NeuriTox assay | Positive | EC25(NA) [Glc/Gal] | 326 | ||
| Oligomycin | 152 μg inhibitor/mg protein | E. coli | membrane vesicle, pH gradient formation | Positive | 170 | |||
| Oligomycin | 7.1 μg inhibitor/mg protein | C. asciculate | SMP-ATPase | Positive | IC50 | 170 | ||
| Oligomycin | 2.0-3.0 μg inhibitor/mg protein | S. cerevisiae | SMP-ATPase | Positive | IC50 | 170 | ||
| Oligomycin | 0.3 μM | human NCI-60 cell lines | F0F1-ATPase | Positive | IC50 | 170 | ||
| Oligomycin | 15 ng inhibitor/mg protein | N. crassa | SMP-ATPase | Positive | Ki | 170 | ||
| Oligomycin | 0.21 μM | bovine | heart MF0F1-ATPase | Positive | Ki | 170 | ||
| Oligomycin | 0.4 μg inhibitor/mg protein | bovine | heart SMP-ATPase | Positive | 95% inhibition | 170 | ||
| Oligomycin | 0.5 μg/ml | rat | liver SMP-ATPase | Positive | 75% inhibition | 170 | ||
| ossamycin | 46 μg of inhibitor/mg protein | E. coli | pH gradient formation by membrane vesicle | Positive | IC50 | 170 | ||
| ossamycin | 8 μM | human NCI-60 cell lines | F0F1-ATPase | Positive | IC50 | 170 | ||
| ossamycin | 1.3 μg of inhibitor/mg protein | S. cerevisiae | SMP-ATPase | Positive | IC50 | 170 | ||
| venturicidin B | Positive | 170 | ||||||
| Bedaquiline | Positive | 170 | ||||||
| tributyltin chloride | 200 nM | E. coli and | F0F1-ATPase | Positive | 170 | |||
| tributyltin chloride | 200 nM | I. tartaricus | F0F1-ATPase | Positive | 170 | |||
| tributyltin chloride | 1 μM | C. thermoaceticum | membrane-bound F0F1-ATPase | Positive | 47% inhibition | 170 | ||
| tributyltin chloride | 5 μM | C. thermoaceticum | membrane-bound F0F1-ATPase | Positive | 87% inhibition | 170 | ||
| tributyltin chloride | 1 μM | TF0F1-ATPase | Positive | 80% inhibition | 170 | |||
| NCCD | 0.65 nmol/mg protein | bovine | heart SMP-ATPase | Positive | IC50 | 170 | ||
| NCCD | 1 nmol NCCD/mg protein | bovine | heart SMP-ATPase | Positive | 85% inhibition | 170 | ||
| substrate analogs | Positive | 170 | ||||||
| tentoxin | ∼0.6 mol/mol | spinach | CF1-ATPase | Positive | IC50 | 170 | ||
| tentoxin | 50 nM | spinach | CF1(-ɛ)-ATPase | Positive | IC50 | 170 | ||
| tentoxin | 0.4-0.6 μM | lettuce | chloroplasts, photophosphorylation | Positive | IC50 | 170 | ||
| tentoxin | 10 nM | spinach | CF1(-ɛ)-ATPase | Positive | Ki | 170 | ||
| tentoxin | 30-60 μM | TF1-ATPase | Positive | Ki | 170 | |||
| tentoxin | 8-10 nM | spinach | CF1(-ɛ)-ATPase | Positive | Kd | 170 | ||
| efrapeptins | Positive | 170 | ||||||
| azide | Positive | 170 | ||||||
| resveratrol | Positive | 170 | ||||||
| N,N'-dicyclohexylcarbodiimide | 0.2 μg of inhibitor/mg protein | S. cerevisiae | SMP-ATPase | Positive | IC50 | 170 | ||
| N,N'-dicyclohexylcarbodiimide | 1-5 μg of inhibitor/mg protein | T. pyriformis | SMP-ATPase | Positive | IC50 | 170 | ||
| N,N'-dicyclohexylcarbodiimide | 200 μMa in less than 5 min and at ∼40 μMa in 30 min | R. rubrum | F1-ATPase | Positive | 170 | |||
| N,N'-dicyclohexylcarbodiimide | 1.9 μg/mg protein | C. fasciculata | SMP-ATPase | Positive | IC50 | 170 | ||
| Oligomycin | 8 nM | bovine | heart mitochondria | Measurement of complex V activity | Positive | IC50 | 3 | |
| aurovertin B | 1.5 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | IC50 | 3 | |
| N,N'-dicyclohexylcarbodiimide | 1 mol DCCD/mol F1 | EF1-ATPase | Positive | 95% inhibition | 170 | |||
| N,N'-dicyclohexylcarbodiimide | 30 μM | membrane-bound EF0F1-ATPase | Positive | maximal 70-80% inhibition | 170 | |||
| N,N'-dicyclohexylcarbodiimide | 5 μM | C. thermoaceticum | membrane-bound F0F1-ATPase | Positive | 47% inhibition | 170 | ||
| N,N'-dicyclohexylcarbodiimide | 2 mol inhibitor bound/mol F1 | bovine | heart MF1-ATPase | Positive | 97% inhibition | 170 | ||
| Amiodarone | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.001 | 3 | |
| N,N'-dicyclohexylcarbodiimide | 1 mol inhibitor/mol F0 | bovine | heart SMP-ATPase | Positive | maximal inhibition | 170 | ||
| N,N'-dicyclohexylcarbodiimide | 2 mol inhibitor/mol F0 | bovine | heart H+-translocation | Positive | maximal inhibition | 170 | ||
| N,N'-dicyclohexylcarbodiimide | 1 mol inhibitor/mol F0 | E. coli | membrane H+-translocation | Positive | maximal inhibition | 170 | ||
| woodward's reagent k | Positive | 170 | ||||||
| Benoxaprofen | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| N,N'-dicyclohexylcarbodiimide | Positive | 170 | ||||||
| woodward's reagent k | Positive | 170 | ||||||
| Bezafibrate | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Enterostatin | Positive | 170 | ||||||
| ethyldimethylaminopropyl carbodiimide | 13 mol of EDC/mol F1 (EF1-ATPase) | Positive | 95% inhibition | 170 | ||||
| 1,5-difluoro-2,4-dinitrobenzene | Positive | 170 | ||||||
| Chlorpromazine | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.001 | 3 | |
| NBD-Cl | Positive | 170 | ||||||
| NBD-Cl | Positive | 170 | ||||||
| Mersalyl | 130 μM | bovine | heart MF0, proton conductivity | Positive | 70% inhibition | 170 | ||
| Dantrolene | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Diclofenac | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.01 | 3 | |
| cyclophilin D | Positive | 171 | ||||||
| Fluconazole | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| gefitinib | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.001 | 3 | |
| Linezolid | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Metformin | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Nefazodone | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.001 | 3 | |
| paroxetine | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.001 | 3 | |
| pravastatin | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Primaquine | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| radicicol | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Rosiglitazone | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Simvastatin | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.001 | 3 | |
| Tamoxifen | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | p < 0.001 | 3 | |
| Diazepam | 140μg/ml | PE cells | potentiometric method | Positive | inhibit 60% | 293 | ||
| trazodone | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Trovafloxacin | 50 μM | bovine | heart mitochondria | Measurement of complex V activity | Negative | p < 0.05 | 3 | |
| Peroxynitrite | 2mM, IC50=0.63mM | rat | heart mitochondria | ATPase activity was assayed by coupling to the reactions of pyruvate kinase with lactace dehydrogenase following NADH oxidation at 340nm | Positive | IC50 | 298 | |
| Tamoxifen | 1.6 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | IC50 | 3 | |
| Tamoxifen | 29 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | IC50 | 3 | |
| Tamoxifen | 26 μM | bovine | heart mitochondria | Measurement of complex V activity | Positive | IC50 | 3 | |